525 B Street, Suite 2200
San Diego, CA 92101


d. (619) 515-3250


San Diego I

Host & Co-Chair

Michael Kinkelaar


Mike is a partner with the firm's Business & Technology team, where he served as Team Leader for over 10 years. He is also a member of the firm's Corporate and Securities practice group, where he served as group leader for 5 years, and a member of the Mergers and Acquisitions practice group, the Emerging Growth and Technology group, and the Licensing practice group. Mike advises clients in business strategy and in corporate, securities, intellectual property and related tax issues in a full range of legal projects. These include mergers and acquisitions, debt and equity financing, including angel and venture capital, licensing, strategic alliances, joint ventures and corporate partnering, equity compensation plans, manufacturing and distribution agreements, technology transactions, and start-up business formation and structuring. Mike has represented companies in a variety of industries, including life science, healthcare, medical devices, information technology, software, hardware, internet, telecommunications, and defense, as well as various retail, service, entertainment, real estate, and manufacturing industries. Mike has also represented US, European, Asian and Latin American companies in various outbound and inbound international transactions, including the establishment of subsidiaries in the United States and varying international jurisdictions.



ADMISSIONS: California


  • Represented an investment banking client and acted as Underwriter’s Counsel for the public offering on NASDAQ for a Florida based medical device company, and later acted as underwriter’s counsel in a follow-on public offering for certain shareholders of the company.

  • Represented a life sciences medical diagnostics company in the negotiation and implementation of a long term development, collaboration and commercialization agreement with a large public pharmaceutical company for a companion diagnostic test necessary for regulatory approval by the FDA of a new cancer drug.

  • Assisted numerous emerging growth and technology companies in seed and angel financings, and later stage private financings and venture capital transactions, including complex related transactions involving both preferred and common stock.

  • Assisted numerous companies in complex mergers and acquisitions and related transactions.

  • Represented technology corporation in negotiating the sale of its biomedical division to a publicly held company for cash and securities, and subsequently renegotiated the transaction to increase proceeds and accelerate payment.

  • Represented biotechnology company in preferred stock sale, and concurrent licensing of ancillary technology, to a public technology company.

  • Assisted start-up medical software company with private securities offering to raise seed capital for research, development and operations and subsequently negotiated the sale of controlling interest to a publicly operated health care group.

  • Appealed and argued an IRS assessment against several related corporations, reducing taxes from $1.7M to $75K.

  • Represented a public company in its joint venture with the City of San Diego to provide emergency medical and ambulance service to the citizens of San Diego, CA.

Highrise Networks, Inc.

800 S. Figueroa, Suite 925

Los Angeles, CA 90017

(213) 712-9080